The big news in biotech this week is the court ruling against Myriad Genetics and gene patents. As Genomics Law Report discusses, this was an overwhelming win for the plaintiffs (which included the ACLU and various research and patients' organizations). The judge issued a summary judgement, which means 1) that both sides of the case agreed on the basic facts, and 2) the law was judged to be overwhelmingly on the plaintiff's side:
I forget how I ran across this link, but this blogger reflects on how six years of blogging has helped his work as a political analyst: